Attacking Aortic Aneurysms Before They Grow

New basic science research shows what happens when you inhibit JMJD3 through both genetics and pharmacology.

1:04 PM

Author | Haley Otman

stethoscope drawing in blue ink on lined paper with lab note writing on bottom right in yellow and navy
Michigan Medicine

A new study investigates a genetic culprit behind abdominal aortic aneurysm, a serious condition that puts people at risk of their aorta rupturing – a potentially deadly event.

Finding a viable genetic target for AAA could change the game, says senior author Katherine Gallagher, M.D., a vascular surgeon and an associate professor of surgery and microbiology and immunology at Michigan Medicine.

That's because there are no medications to directly treat the condition and prevent an aneurysm from growing. Current options include things like addressing blood pressure to lower the stress on the arteries and veins running through the body, and making lifestyle changes like quitting smoking. Most people monitor their aneurysm to see if it grows enough to eventually require endovascular or open surgical repair.

For this study, a team of Michigan Medicine researchers investigated the role of an epigenetic enzyme called JMJD3 in the development of AAAs. They found the gene was turned on in both people and mice who had an AAA and that the gene promoted inflammation in monocyte/macrophages. When they blocked the enzyme, it prevented an aneurysm from forming.

"Targeting the JMJD3 pathway in a cell specific-manner offers the opportunity to limit AAA progression and rupture," says lead author Frank Davis, M.D., a vascular surgery resident at the Frankel Cardiovascular Center.

"We are the first to perform an extensive single-cell RNA sequencing and gene expression analysis on human AAAs and non-aneurysmal aortic control samples," Gallagher adds.

Paper cited: "Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms," Journal of Experimental Medicine. DOI: 10.1084/jem.20201839


More Articles About: Lab Notes Aortic Aneurysm Basic Science and Laboratory Research Genetics Cardiovascular: Treatment & Surgery Cardiovascular: Diagnostics & Procedures Community Health Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories chess pieces yellow background one red piece on right and yellow on left weighing the balance beam down
Health Lab
Interplay between key proteins could serve as a target for cancer treatment
University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.
Smiling black and white photo of Phil Jenkins seated at his desk. He is dressed up in a button-up shirt and tie.
Philanthropy News
$3M Jenkins Foundation Gift Ensures Future of Depression Outreach Programs
Jenkins Foundation makes $3 million gift to the Kenneth and Frances Eisenberg and Family Depression Center to sustain outreach and community education programs.
hands on a robotic handle for surgery
Health Lab
Bile duct injury rates higher from robotic assisted cholecystectomy
Robotic-assisted cholecystectomies produce a higher risk of bile duct injuries than laparoscopic cholecystectomies for patients at all types of risks.
inhaler green money sign floating in cloud and little girl with black hair coughing
Health Lab
Children on Flovent for asthma more likely to stop inhaled steroids after drug pulled from market
The discontinuation of a popular asthma medication was linked to a higher rate of children stopping inhaled steroid therapy altogether, a study suggests.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.